Approval · Notice of Compliance 7904 · 2006
VELCADE: Notice of Compliance 7904
Issued April 24, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 7904
- Date
- April 24, 2006
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for stem cell transplantation
- Therapeutic class
- Antineoplastic agent
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VELCADE | Not yet assigned | — |
Medicinal ingredients
- BORTEZOMIB MANNITOL BORONIC ESTER 3.5 MG per VIAL